Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate Cancer
Status:
Completed
Trial end date:
2016-01-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Bicalutamide and
goserelin may fight prostate cancer by reducing the production of testosterone. It is not yet
known if radiation therapy is more effective with or without bicalutamide and goserelin in
treating prostate cancer.
PURPOSE: Randomized phase III trial to compare the effectiveness of radiation therapy with or
without bicalutamide and goserelin in treating patients who have localized prostate cancer.
Phase:
Phase 3
Details
Lead Sponsor:
European Organisation for Research and Treatment of Cancer - EORTC